MSF experiences of providing multidisciplinary primary level NCD care for Syrian refugees and the host population in Jordan: an implementation study guided by the RE-AIM framework. by Ansbro, Éimhín et al.
RESEARCH ARTICLE Open Access
MSF experiences of providing
multidisciplinary primary level NCD care for
Syrian refugees and the host population in
Jordan: an implementation study guided
by the RE-AIM framework
Éimhín Ansbro1* , Tobias Homan2, Jamil Qasem3, Karla Bil4, Mohammed Rasoul Tarawneh5, Bayard Roberts1,
Pablo Perel1 and Kiran Jobanputra6
Abstract
Background: In response to the rising global NCD burden, humanitarian actors have rapidly scaled-up NCD
services in crisis-affected low-and-middle income countries. Using the RE-AIM implementation framework, we
evaluated a multidisciplinary, primary level model of NCD care for Syrian refugees and vulnerable Jordanians
delivered by MSF in Irbid, Jordan. We examined the programme’s Reach, Effectiveness, Adoption and acceptance,
Implementation and Maintenance over time.
Methods: This mixed methods retrospective evaluation, undertaken in 2017, comprised secondary analysis of pre-
existing cross-sectional household survey data; analysis of routine cohort data from 2014 to 2017; descriptive
costing analysis of total annual, per-patient and per-consultation costs for 2015–2017 from the provider-perspective;
a clinical audit; a medication adherence survey; and qualitative research involving thematic analysis of individual
interviews and focus group discussions.
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Results: The programme enrolled 23% of Syrian adult refugees with NCDs in Irbid governorate. The cohort mean
age was 54.7 years; 71% had multi-morbidity and 9.9% self-reported a disability. The programme was acceptable to
patients, staff and stakeholders. Blood pressure and glycaemic control improved as the programme matured and by
6.6 mmHg and 1.12 mmol/l respectively within 6 months of patient enrolment. Per patient per year cost increased
23% from INT$ 1424 (2015) to 1751 (2016), and by 9% to 1904 (2017). Cost per consultation increased from INT$
209 to 253 (2015–2017). Staff reported that clinical guidelines were usable and patients’ self-reported medication
adherence was high. Individual, programmatic and organisational challenges to programme implementation and
maintenance included the impact of war and the refugee experience on Syrian refugees’ ability to engage;
inadequate low-cost referral options; and challenges for MSF to rapidly adapt to operating in a
highly regulated and complex health system. Essential programme adaptations included refinement of health
education, development of mental health and psychosocial services and addition of essential referral pathways,
home visit, physiotherapy and social worker services.
Conclusion: RE-AIM proved a valuable tool in evaluating a complex intervention in a protracted humanitarian crisis
setting. This multidisciplinary programme was largely acceptable, achieving good clinical outcomes, but for a
limited number of patients and at relatively high cost. We propose that model simplification, adapted procurement
practices and use of technology could improve cost effectiveness without reducing acceptability, and may facilitate
replication.
Keywords: Non communicable disease, Diabetes, Hypertension, Cardiovascular disease, Humanitarian, Conflict,
Effectiveness, Refugee, Syria, Jordan, Programme, RE-AIM, Evaluation, Implementation
Background
In recent years, humanitarian actors have had to rapidly
scale-up NCD services in response to the rising glo-
bal burden of NCDs and to the specific crises involving
middle-income countries with high NCD burdens [1, 2].
There is strong evidence on cost-effective, primary care-
based clinical management of NCDs in stable, high-
income countries. However, there are limited clinical
and programmatic tools available to guide NCD inter-
ventions in low- and middle-income countries (LMICs)
and even less addressing those affected by humanitarian
crises and forced displacement [3–5]. The literature de-
scribing NCD programme implementation or evaluation
in humanitarian settings is especially limited [6, 7]. In re-
sponse to this gap, humanitarian actors, including the
medical humanitarian non-governmental organisation
(NGO) Médecins sans Frontières, have adapted their
traditional approaches to care for chronic disease, devel-
oping clinical and programmatic guidance, monitoring
and evaluation tools and an NCD emergency response
kit [8, 9]. As they have gained increasing experience of
NCD care delivery, some humanitarians have called for
the sustainability of NCD interventions to be considered
in their design and for handover to local health struc-
tures to occur during protracted crises [2].
The challenges of evaluating interventions in humani-
tarian settings are well known [10–13]. Traditional ex-
perimental methods may be unfeasible or even unethical
to implement in such settings; target populations are
vulnerable and humanitarian contexts are dynamic and
potentially insecure; and there may be limited skills, time
and funding available for research and evaluation within
humanitarian organisations [11]. There is a clear need to
develop robust strategies to evaluate programmes in dis-
aster settings that are rapid, pragmatic and that impose
minimal burden on implementing teams [13]. RE-AIM
is an implementation research framework that has been
used successfully for planning and evaluating interven-
tions in both high-income and LMIC settings [14]. To
the best of our knowledge, it has not yet been compre-
hensively applied to a humanitarian intervention. It was
designed to facilitate the translation of research into
practice and to improve the reporting of key elements
essential for successful programme implementation, at
both individual- and organisational-levels [14–18]. Using
mixed methods, the framework assesses programmes
under five key domains: reach, effectiveness, adoption,
implementation, and maintenance (Table 1).
The Syrian conflict, now in its tenth year, continues to
devastate the Syrian people. Since 2011, over 6.1 million
Syrians have been internally displaced, while over 6.6
million have fled as refugees, mostly into surrounding
countries [22]. Jordan currently hosts almost 670,000
Syrian refugees registered with the United Nations High
Commissioner for Refugees (UNHCR). Globally, it ranks
second only to Lebanon in the number of refugees it
hosts relative to the national population [22, 23].
NCDs have been responsible for more deaths than
communicable diseases in Syria for several decades,
causing 77% of mortality before the conflict [24, 25]
Therefore, host country and humanitarian actors have
had to tackle the high NCD burden amongst Syrian
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refugees [23, 26–28]. In Jordan, the Ministry of Health
(MOH) has been strengthening NCD care at primary
level to address the rising NCD burden among its own
population. At the time of this study, NCDs were diag-
nosed and monitored by family medicine specialists at
MOH comprehensive primary centres while medication
refills were provided by non-specialist doctors at primary
health centre level. UNHCR funded registered Syrian
refugees to access MOH primary care services and lim-
ited referral services. However, financial barriers
Table 1 Example indicators and data method/source based on the RE-AIM domains





• Target population reached?
Coverage ▪ % people among the target population eligible for
programme and number served by the programme
▪ Prevalence of NCD and MH comorbidityb
• Existing MSF
household survey a
• Routine cohort data
• Qualitative data
“Effectiveness”/ Quality of Care
▪ Trends in clinical outcomes and quality
indicators?
▪ Perceived benefits/unintended




▪ % HTN patients with most recent BP < 140/90 mmHg, 6 &
12 months post enrolment and trend from baselineb
▪ % Patients with diabetes with last HbA1c < 8.0% 6 &
12 months post enrolment and trend from baselineb
▪ % Patients who report decreased/quitting smoking




▪ % activec CVD patients prescribed a statin
▪ % COPD/ asthma patients with inhaler technique check
documented
▪ Trend in defaultersc and deaths as a proportion of active cohort
• Clinical audit
• Routine cohort data
Perceived
Effectiveness
▪ Patients’ and providers’ perspectives on effectiveness of




▪ Care model accessible and acceptable
to patients, providers, organisation and
community?
▪ Guideline acceptable to staff?
Accessibility/
acceptability
▪ Availability and accessibility / barriers to access
▪ Acceptability/usability of NCD guideline
▪ Self-reported medication adherence and medication beliefs







▪ Description of intervention location, cadres of staff and
qualifications
▪ Experience of receiving and providing NCD care, use of clinical
guideline
▪ How participation influenced patient/staff well-being and/or
work practices
▪ Routine cohort data
▪ Qualitative data
Implementation
▪ Intervention delivered as intended?
▪ Facilitators and barriers to implementing the
programme?






▪ % DM patients with micro-albuminuria or urinary protein tested
▪ % Activec cohort attending a health education session at last
clinical visit
▪ No. of MHPSS group sessions monthly during reporting period
▪ Clinical audit
▪ Routine cohort data
Adaptations • NCD care adaptations to local setting (e.g. cultural; dietary,
exercise)
• Programme adaptations related to humanitarian setting e.g.
response to patients’ psychosocial needs
▪ Qualitative data
Cost • Staff time;




▪ Staff time estimates
Maintenance
• Challenges and facilitators for patients
to stay in programme?
• Organisational challenges, and costs;
adaptations made to maintain programme?
Individual
Level
• % Patients activec 6 months post enrolmentb
• Self-reported medication adherence rates
• Key challenges in altering lifestyle (diet, exercise, smoking)











• Measures of cost of maintenanceb
• Institutionalisation of the programme/modifications made for
maintenance
• Alignment with organisational mission
Key: BP blood pressure, COPD chronic obstructive pulmonary disease, CVD cardiovascular disease, HbA1c glycosylated haemoglobin, HLO humanitarian
liaison officer, HV home visit, MH mental health, MHPSS mental health and psychosocial support, NCD non-communicable disease
aRelevant methods and results are reported in Rehr et al. [19]
bDetailed methods and results are reported in linked papers [20, 21]
c“Active patients” means continued to attend the service and not exited [i.e. died, departed the area or defaulted (i.e. have not attended for more than
90 days since their last planned appointment)]
Ansbro et al. BMC Health Services Research          (2021) 21:381 Page 3 of 19
(including the addition of user co-payments from 2014,
which have varied over time reaching full “foreigner”
rate by 2018), complex care pathways and referral
systems, and limited health facility capacity have
impeded refugees’ access to these services [29]. The
burden, access issues and the broader health system re-
sponse to Syrian refugees’ NCD needs in Jordan are well
documented [19, 29–31]. However, little is known about
the content or quality of current NCD programming, ei-
ther within the MOH or parallel humanitarian health
systems.
Since 2014, Médecins sans Frontières (MSF), a hu-
manitarian medical organisation, has supported the Jor-
danian health system by providing multidisciplinary,
primary level NCD care to Syrian refugees and the vul-
nerable host population in Irbid, north Jordan. In re-
sponse to the urgent need for evidence to guide
humanitarian actors in tackling NCDs in complex set-
tings, we undertook a mixed methods evaluation of the
MSF programme. We hoped to learn lessons to both im-
prove the current care model and to inform the design
of future NCD programmes in Jordan and elsewhere.
Detailed analyses of cohort, qualitative and costing data
are reported in separate papers [20, 21, 32]. The aim of
this paper was to summarise the full evaluation, which
used the RE-AIM implementation framework to exam-
ine the Reach; Effectiveness; Adoption and acceptance of
the programme; Implementation fidelity, adaptations and
costs; and programme Maintenance over time [33].
Methods
This retrospective mixed methods evaluation of the MSF
NCD programme in Irbid comprised secondary analysis
of data from a pre-existing cross-sectional household
survey [19], analysis of routine cohort data, a descriptive
costing study, a clinical audit, a self-administered medi-
cation adherence survey and qualitative research. It was
undertaken in late 2017 and covered the study period
December 2014 to December 2017. This paper draws to-
gether the findings from all methodologies under the
RE-AIM framework. Example indicators, based on the
RE-AIM domains, and the relevant methods and data
used to determine them are presented in Table 1. The
full list is available in Supplementary Material 1.
Study setting
The study was conducted in Irbid, the second largest city
in Jordan. Irbid governorate hosted over 165,000 Syrian
refugees who were mostly urban-based [34]. MSF com-
menced an NCD service within a Ministry of Health
(MOH) primary care facility in Irbid in December 2014
serving non-camp dwelling Syrian refugees and the vul-
nerable Jordanian host community. A second site in the
city was opened within a local NGO clinic in April 2016.
The MSF service was vertical, operating in parallel to
the pre-existing activities at each site rather than inte-
grating with them. Medicines, consultations and labora-
tory investigations were provided free-of-charge to
patients. The cohort size was capped by MSF at approxi-
mately 4000 for operational and cost reasons and the
two sites were later amalgamated in 2019.
Intervention
Detailed descriptions of the context, the intervention
and a programme timeline are appended in the supple-
mentary material (S2 and S3). In brief, this was a multi-
disciplinary, primary care model, which used context-
adapted clinical guidelines, generic medications in line
with the World Health Organization (WHO) Essential
Medicines list and task sharing.
Enrolment
Eligibility for enrolment required both medical and so-
cial indications. The target medical conditions were:
hypertension (HTN), established cardiovascular disease
(CVD) [angina, myocardial infarction, ischaemic stroke,
transient ischaemic attack, peripheral vascular disease,
congestive heart failure], diabetes mellitus (DM) type I
or II, chronic obstructive pulmonary disease (COPD),
asthma or hypothyroidism). Hereafter, these are referred
to as “target NCDs”. Social indications included being a
Syrian refugee (either registered or unregistered with
UNHCR), a refugee of other origin or a vulnerable mem-
ber of the Jordanian host population. Jordanians were
considered vulnerable if they either lacked Jordanian na-
tional health insurance (and were therefore subject to
co-payments to access MOH care) or were of low socio-
economic status. This was assessed using “vulnerability
criteria” developed by the programme. Enrolment cri-
teria changed over time, for example isolated
hypothyroidism was removed and vulnerability criteria
were adapted for ease of implementation. Enrolment
was not limited by place of residence or age. Most pa-
tients presented with established, self-reported diagno-
ses; new diagnoses were made based on the MSF NCD
guideline [8].
Service description
The multidisciplinary team initially included non-
specialist doctors, nurses, health educators, pharmacy
and reception staff, who provided appointment-based
medical consultation, health education and behaviour
change counselling, supported by a local management
team and a coordination team in Amman. The service
evolved to also incorporate individual- and group-based
mental health and psychosocial support (MHPSS), social
work, physiotherapy and a home visit service for house-
bound patients, with the addition of counsellors, a
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humanitarian liaison officer, a home visit doctor and
nurses, a physiotherapist and specialist family medicine
practitioners. Facility-based services were provided 6
days per week from 8 am to 2 pm, while the home visit
service operated on 6 days within a ten-mile radius of
the clinics. By 2017, the team had introduced task shar-
ing of some review visits. Further detail is available
below and in Supplementary Material (S2 and S3).
Study design
The RE-AIM domains were defined with reference to
the relevant literature [14–17] and with some adapta-
tions specific to this evaluation. Reach was defined as
coverage of the NCD service and its components to the
intended target population, with a focus on MHPSS ser-
vices. RE-AIM defines effectiveness as the impact of an
intervention on important outcomes, including potential
negative effects, quality of life and costs. Effectiveness
was determined by examining: 1) trends in intermediate
clinical outcomes, 2) quality of care indicators, 3) per-
ceived benefits, unintended consequences and behav-
ioural outcomes, and 4) economic outcomes. Adoption /
acceptance were explored in relation to the organisation,
setting, staff and patients and included changes to be-
haviour and practice. The Adoption domain is usually a
“setting-level” outcome, defined in the literature in terms
of absolute number, proportion, and representativeness
of settings and intervention agents who are willing to
initiate a program. Since this definition was not relevant
to the MSF programme, as there was no choice for staff
or settings to take part, we adapted this domain to cover
patient adoption of the programme, including access
and acceptability. Implementation of the NCD service
was explored in relation to each programme component.
We examined the fidelity of guideline implementation
and its usability; the adaptation of structures, processes
and tools; and the costs of implementation. Maintenance
referred to the continued implementation of the NCD
service over time by patients, the programme team and
the organisation. The specific indicators and methodolo-
gies used to operationalize these definitions are listed in
Table 1 and Supplementary Material 1. Qualitative and
quantitative data from the various data sources were
synthetized using the RE-AIM framework.
Study participants, data collection and analysis
Household survey
To explore programme coverage, we used previously re-
ported data from a Household Access and Utilisation
Survey conducted by MSF in Irbid governorate, north
Jordan in 2016. MSF undertook the survey to inform
health service planning for the refugee population. They
estimated the prevalence of NCDs and NCD multi-
morbidity and determined factors associated with high
NCD prevalence. Data collection and analysis, using a
two-stage cluster design, are described in detail else-
where [19].
Retrospective cohort study
To explore cohort demographics, NCD prevalence and
service use, we analysed data from all patients who ever
attended an enrolment visit in MSF’s NCD clinics from
December 2014 to December 2017. Descriptive statistics
were used to examine patient demographics and process
indicators. We explored trends in intermediate clinical
outcomes and treatment interruption from programme
and patient perspectives, and the factors associated with
these trends. We included patients 18 years and older
with hypertension and/or diabetes type II (DM II), ex-
ploring control of systolic blood pressure (SBP < 140
mmHg) and glycaemia [fasting capillary blood glucose
(FBG) ≤ 180 mg/dL or HbA1c < 8%] [21]. We plotted
monthly means for each outcome (SBP, FBG, HbA1c or
treatment delay) and the proportion of monthly visits at
which targets were achieved. We used Generalised Lin-
ear Mixed-Effects Models (GLMM) to explore factors
associated with each outcome. The analysis is elaborated
on in our related paper [21]. Routine paper-based clin-
ical data were collected by MSF data clerks and entered
into a bespoke password-protected Microsoft Excel soft-
ware database. Cohort data from both clinical sites were
aggregated and analysed using R v1.0.136 (R, Boston,
MA 02210, USA).
Costing study
A descriptive costing analysis from the provider perspec-
tive aimed to explore the annual total, per patient and
per consultation costs for the Irbid NCD programme for
2015, 2016 and 2017. The analysis delineated capital and
recurrent costs incurred at clinic- and project team-
levels in Irbid and coordination team-level in Amman.
Recurrent costs included human resources, medicines
and equipment, building and vehicle costs, and training
and supervision. We excluded direct or indirect patient-
incurred costs. The analysis is described in detail in our
companion paper [20].
Clinical audit
The clinical audit aimed to explore programme quality
by examining fidelity of guideline implementation. We
used a random selection of paper files from patients en-
rolled at least 12 months in the programme. Data were
collected in August 2017 by programme medical staff on
a paper-based checklist and entered into a purpose-
designed Excel spread-sheet. We used process indicators
analysed using descriptive statistics (Table 1; S1).
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Medication adherence survey
A convenience sample of 300 consenting patients aged 18
or over attending either MSF clinic site during a 2-week
period in September 2017 was selected (Supplementary
material S4). The 17-item adherence survey included
demographic information and pre-existing self-reported
medication adherence and beliefs measures: the Medica-
tion Adherence Report Scale-5 item (MARS-5) and the
Beliefs About Medicines Questionnaire (BMQ). Two
trained data collectors took written informed consent
from patients, who self-filled the survey in Arabic. Data
collectors assisted those with limited literacy. Paper data
were held securely and were entered into a purpose-
designed Excel tool. Analysis included descriptive statistics
and multivariate logistic regression.
Qualitative study
The methods are described in detail in Supplementary
material S5. In brief, this involved two same-sex focus
group discussions (FGDs) with eight Syrian adult pa-
tients each and 40 individual semi-structured interviews,
including 16 with adult Syrian and Jordanian patients,
18 with MSF staff, and seven with key stakeholders, in-
cluding staff from the MOH and other international
NGOs involved in NCD care delivery. Data were
collected by two local researchers and the principal
researcher, in Arabic and English, in August 2017. EA
and a second analyst (LM) performed thematic analysis,
based on the RE-AIM framework, using a combination
of inductive and deductive coding.
The findings are reported in accordance with the Con-
solidated Criteria for Reporting Qualitative Research
checklist for transparency [35]. Mental health and social
suffering emerged as prominent, data-derived themes
and have been reported in detail separately [32]. The
remaining themes are reported here.
This study protocol was granted approval by the MSF
Ethics Review Board and LSHTM Ethics Committee.
Written authorisation to implement the study was ob-
tained from the Ministry of Health of Jordan.
Results
The results are presented according to each RE-AIM do-
main and subdomain (Table 1). These have been some-
what reordered compared to our protocol to facilitate
logical presentation.
Reach
We explored the numbers eligible for the programme,
numbers reached and representativeness of those
reached. The project proposal defined the target popula-
tion as Syrians with target NCDs resident in Irbid gover-
norate. To explore access and coverage, MSF performed
a Household Access and Utilisation Survey in 2016.
Results showed one fifth of surveyed adult Syrians in
Irbid governorate self-reported at least one NCD tar-
geted by MSF (21.8% of 8041 surveyed adults aged 18 or
over). UNHCR and others estimated that 95% of refu-
gees resident in Irbid governorate in 2017 were regis-
tered with UNHCR (n = 135,144 in December 2017) of
whom 48.7% were adults aged ≥18 years [19, 36]. This
implies there were 142,256 total refugees with 69,278 ≥
18 years. Applying the household survey figure of 21.8%
meant 15,102 Syrian refugees ≥18 years in Irbid gover-
norate had an MSF-targeted NCD and were therefore
eligible for enrolment in the programme. Since 3531
Syrian adult patients were ever-enrolled (limited by the
cap on cohort size), 23.4% of the target population was
reached by this MSF programme [37]. Syrians resident
in other governorates were also eligible. Patients were
enrolled on a first-come-first-served basis and news of
the programme quickly spread by word of mouth. The
Jordanian government required that international med-
ical providers enrolled a varying proportion of the host
community in their programmes. MSF defined its own
‘vulnerability’ criteria which took into account economic
as well as social factors, with reference to the Jordanian
Ministry of Social Welfare. The definition of eligibility
(vulnerability) changed over time.
Retrospective data were analysed from 5045 patients ever
enrolled during the study period. The cohort comprised
3664 (72.6%) Syrians, 1365 (27.1%) Jordanians and 16
(0.3%) refugees of other origins (Palestinian or Iraqi), who
were middle-aged [mean 54.7 years (SD 15.7)] with multi-
morbidity and relatively high rates of self-reported disability
(9.9%). The majority (59.8%) were women and 71% (n =
3582) had two or more target NCD conditions, with hyper-
tension (60.4%), type 2 diabetes (53.1%), cardiovascular dis-
ease (25.9%), hypothyroidism (7.6%) and asthma (7.0%) the
most commonly treated conditions (Supplementary mater-
ial S6). These findings are consistent with the MSF House-
hold Access Survey, which reported a similar prevalence of
target NCDs [19]. However, the MSF clinic cohort had
greater rates of NCD multi-morbidity compared to the
adults with NCDs in the household survey (71% vs. 44.7%).
NCD risk factor levels were high at enrolment with obesity
levels of 62.6%, self-reported smoking rates of 22.7%, and
low or zero self-reported regular physical activity in 37.2%
(Supplementary material S6). The reach of the MHPSS ser-
vice is described below.
Access, acceptance and adoption
Under this domain, we described the programme’s com-
ponents, structures and staffing and we explored patient,
provider and stakeholder perspectives on programme
accessibility.
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Accessibility
We considered access in terms of availability, cost and phys-
ical accessibility. MSF services were available to 23.4% of
their targeted Syrian population. MSF took a “cohort ap-
proach” to their service provision and both MSF and Jordan-
ian policy required services to also be delivered to the host
population. MSF’s policy of providing free-of-charge care fa-
cilitated access for the enrolled Syrians and vulnerable Jorda-
nians to medical consultation, consistent medication supply
and laboratory testing. Patients only incurred transport and
indirect costs, such as loss of income. Syrian interviewees, in
particular, reported carefully balancing stretched household
finances, and prioritising expenditure on transport costs for
aspects of the MSF service they valued, such as medical con-
sultations, over those for MHPSS, health education or la-
boratory visits. Some chose to purchase their preferred
medications from other sources if not provided by MSF.
Patients reported the MSF clinics were also accessible
in terms of distance, transport and convenience.
We also explored Syrian community members’ access
to alternative, affordable primary level NCD services in
north Jordan, since MSF’s future programme plans
hinged on whether such a source of affordable NCD care
was available.
“…access to good quality care… that is reliable and
regular and predictable…. I think that is a big chal-
lenge. Affordability is another challenge…” MSF
management staff member.
The MSF Household Access Survey corroborates our
qualitative finding that cost was the main barrier to
obtaining NCD care from other providers. Around a
quarter of surveyed adult refugees with self-reported
NCDs did not seek care when they felt it was needed.
Only 10% reported poor availability as the reason, while
the majority (60%) cited cost. Among those who re-
ceived care, around half made a co-payment [19]. Inter-
viewed MSF patients described their difficulty in
obtaining a regular supply of affordable NCD medica-
tions before enrolling with MSF:
“It’s difficult to buy the medicine always because I
can’t afford it. Thank god when I registered at (the
MSF clinic) … I started to have it free. Before I used
to take from other places by small amounts of money
(or) from the community pharmacy I paid it all.”
Syrian FGD participant.
Other international NGOs also provided NCD care to
registered and unregistered refugees in Irbid governorate
with some requiring co-payments. Registered refugees’
access to MOH primary care clinics was initially free-of-
charge but increasing co-payments were introduced
from 2014 and most interviewed patients described such
co-payments, coupled with travel costs as unaffordable.
Despite the other available options, MSF staff reported
they had a long waiting list of people wishing to access
the MSF service. When asked how NCD patients in their
community who were not enrolled in the MSF
programme coped, interviewees reported that they
skipped medications, shared with family or neighbours
or purchased from private pharmacies:
Syrian patient: “If there is a family that can’t bring
medicine, we collect pills from here and here, so
people help each other ... because there is extra. So
people give to each other. I know a kid who takes in-
sulin…I give to people. I’m forced to help people.”
Staff perceived that most Jordanian patients did not, in
fact, meet vulnerability inclusion criteria and could,
therefore, access alternative free-of-cost services via na-
tional or military insurance. This was the case for all
interviewed Jordanian patients.
We focused particularly on the theme of access to spe-
cialist referral services. In the middle-income setting of
Jordan, secondary and tertiary care services were widely
available within the public and private sector, including
essential NCD referral services such as ophthalmology,
endocrinology, cardiology, nephrology and emergency
services. However, as described by our interviewees,
accessing specialist services for NCD complications or
other conditions via the humanitarian system referral
pathway was complex, inconsistent and burdensome for
patients, while accessing them directly was costly. In
addition to funding primary level MOH access, UNHCR
funded registered and unregistered refugees’ access to
limited public and private specialist services via their
implementing partner Jordan Health Aid Society (JHAS).
JHAS played a gatekeeper role and interviewees from
MSF and other NGOs perceived their decision-making
process as “unhelpful” and lacking clear criteria:
“We don’t really have any … clear structure dealing
with (specialised secondary referrals). The identified
system through JHAS and UNHCR, as the funding
partner, is complex and lacks clarity and doesn’t al-
ways suit our patients.” MSF clinical staff member.
MSF clinical staff could also refer patients to services pro-
vided by other NGOs but felt frustrated and disempow-
ered by the lack of clarity and consistency regarding
referral pathways, the lack of information returned by
most referral services and lack of direct referral pathways
to MOH specialist care. To address this, MSF had bro-
kered agreements with other NGOs to provide retinop-
athy screening and angiography free-of-cost to patients as
Ansbro et al. BMC Health Services Research          (2021) 21:381 Page 7 of 19
part of a defined short-term project. MSF, MOH and
other interviewed stakeholders, suggested that encour-
aging other international NGOs to fund and implement
similar services was the only way to fill the referral gap,
since international funding was limited and dwindling.
Acceptance and adoption/participation
Under this domain, we described the programme loca-
tion, cadres of staff and qualifications. During interviews
we explored patients’, staff and stakeholders’ acceptance
of the programme. With patients, we explored their
sources of information and support; their experiences of
receiving NCD care and how programme participation
influenced their well-being.
Most programme elements were acceptable to patients,
staff and stakeholders. Interviewed patients felt they re-
ceived trusted, good quality care in a caring and respectful
environment. Patients reportedly valued free-of-charge
medications, regular laboratory and vital sign testing most
highly but also valued healthy living advice and “encour-
agement” given by staff. One female patient reported:
“(MSF is) honestly caring about the patient, caring
about his appointments even the medication avail-
ability. We have never come here and told us that
the medication is not available. Their performance
is great.”
Patients favourably compared their experience in the
MSF clinic with their prior experiences at other NGO-
or MOH-provided services. However, several expressed
frustration at MSF narrow range of services and the lim-
ited provision of specialist care.
MSF national and international staff generally prided
in their work for MSF:
“…Syrians, we save their lives, … for me this service
is like life… this disease is very difficult and chronic
…and treatment costs a lot.” Clinic staff member.
Clinical staff were mainly Jordanian medical and para-
medical university graduates, many with previous NGO
experience. They were committed to the MSF team and
their patients and derived satisfaction from observing
patients’ improvements.
“I learned here how to see others’ problems… the dis-
aster they are coming from…how we work here like a
team or a family for the benefit of the patients; how
you can give to the people…without taking, with
nothing in return.” Clinical staff member.
There was low turnover among clinical cadres other
than non-specialist doctors, who tended to resign after
gaining several months’ experience with MSF to pursue
specialist training. This turnover was considered prob-
lematic by clinical supervisors, other staff and patients,
all of whom valued continuity of care. A minority of staff
expressed dissatisfaction with the perceived lack of pro-
motion opportunities or job security (given the limited
duration of MSF programmes), high workload and six-
day working week. Interviewed stakeholders valued the
programme since it relieved a significant burden on the
MOH. Several called for it to be expanded in terms of
coverage and scope (for example, by financing specialist
referral care).
Effectiveness
To evaluate Effectiveness, we examined clinical and qual-
ity indicators (Table 2) using retrospective analysis of
routine clinical and programmatic data and clinical
audit. Perceived effectiveness was explored using qualita-
tive data.
Clinical indicators
Among 4044 adult patients meeting our inclusion cri-
teria (i.e. diagnosed with hypertension and/or Type II
diabetes (DMII) and enrolled during the study period),
2912 (72.0%) had hypertension and 2546 (63.0%) had
DM II, while 1530 (37.8%) had a dual diagnosis. Within
the programme’s first 6 months, mean systolic blood
pressure decreased by 12.4 mmHg from 143.9 mmHg
(95% CI 140.9 to 146.9) to 131.5 mmHg (95% CI 130.2
to 132.9) among hypertensive patients, while fasting glu-
cose improved by 1.12 mmol/l, from 10.75 mmol/l (95%
CI 10.04 to 11.47) to 9.63 mmol/l (95% CI 9.22 to 10.04),
among type II diabetic patients. The probability of
achieving treatment target in a visit was 63–75% by end
of 2017, improving with programme maturation but
with notable seasonable variation. From the patient per-
spective, the mean SBP in hypertensive patients de-
creased by 6.6 mmHg within the first 6 months, from
mean 137.9 mmHg (95% CI 137.1 to 138.7) at entry/new
diagnosis to 131.3 mmHg (95% CI 130.3 to 132.3) Simi-
larly, there was a marked improvement in FBG level by
1.43 mmol/l from a mean of 10.40 mmol/l (95% CI 10.19
to 10.62) at entry/new diagnosis to 8.97 mmol/l (95% CI
8.67 to 9.26) by 6 months; most of this improvement oc-
curred within the first 3 months. These results and those
related to treatment interruption are elaborated on in
our companion paper [38].
Quality indicators
Additional clinical outcome and process indicators are
presented in Table 2. At each health education session
patients were asked to categorise their exercise level as
active, inactive, moderately active, and moderately
inactive but exercise was not otherwise quantified.
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Activity levels did not seem to improve significantly. We
could not determine whether smoking behaviour had
changed since it was not quantified and patients’ self-
reported smoking behaviour change was only recorded
relative to their previous visit. Some activities were
under-performed such as statin prescribing, CVD risk
scoring and performance of annual urinary protein test-
ing in diabetic patients. There appeared to be good levels
of asthma control with only 2.6% of patients with asthma
reportedly having an exacerbation within the preceding
6 months. However, rates of statin prescribing were low
for patients with CVD (25%).
Perceived effectiveness
Interviewed staff and patients perceived the programme
as effective. Patients reported feeling physically and psy-
chologically better after attending the programme, link-
ing this to having a regular supply of medications and
some relief of their financial burden. A Jordanian patient
noted: “I feel relieved and comfortable since the first day
I came here, I felt the difference in my disease.”
Implementation
Under this domain, we examined the fidelity of
programme delivery, the challenges and facilitators to
implementation, the subsequent adaptations made and
the costs of programme delivery.
Fidelity of programme delivery
Indicators exploring fidelity of programme implementa-
tion are presented in Table 3 and were determined via
routine cohort data analysis and clinical audit.
Health education was reportedly not delivered as
intended. Clinical supervisors described the staff’s style
as “didactic”, “harsh” and “combative”. Staff used a
knowledge-based approach with patients, which involved
Table 2 Effectiveness indicator results
Result or comment
a. Clinical Outcome Indicators
%≥ 0.5 mmol/L reduction in total cholesterol from
enrolment to last visit (those enrolled > = 90 days)
Among those with a cholesterol test who were in the cohort for at least 90 days
(2585), 651 had ≥ reduction of 0.5 mmol/L in total cholesterol = 25.1%
% patients with asthma free from exacerbations/
admissions in previous 6 months
Among 382 patients with asthma, only 25 recorded exacerbations in total during the
3-year study period.
% patients who report decreased/quitting smoking Not available as self-reported smoking category (stopped, decreased, increased, re
sumed, unchanged) was reported relative to the last appointment.
% patients who report increased levels of exercise from
baseline
At each visit the category (active, inactive, moderately active, and moderately inactive)
for recent activity behaviour was recorded. 3347 patients enrolled in the project at
least 90 days had a first and last measurement. 610 (18.2%) had improved activity. 593
(17.7%) had worse activity. 2144 (64.1%) stayed the same. There was no significant
improvement (chi sq. =0.284, p = 0.594).
Trend in referrals to another facility for acute
complications/specialist care (% of active cohort)
Trend in referral by type of referral service and volume of referrals were analysed
b. Quality (Process) Indicators
% recommended referrals to other services that are
appropriate as per guideline
Not tested
% of active patients with CVDa prescribed a statin N = 369 (25.8%)
% of patients with CVDa prescribed aspirin N = 717 (50.1%)
% of patients with CVDa prescribed at least one anti-
hypertensiveb drug
N = 1007 (70.4%)
% of patients with asthmac with inhaler technique
check documented
N = 48 (94%)
No./% of times when appropriate clinical action taken
based on clinical or laboratory findings
Among 130 randomly audited diabetic patient files, 100% had cholesterol checked; 73.8%
(n = 82) had a CVD risk score subsequently calculated. Of these, 65.9% had a statin
correctly prescribed (or not prescribed) according to MSF guidelinesd.
Description of cohort deaths 2.6% (n = 139) of enrolled patients died by end of study period. Deaths were determined
by word of mouth and a defaulter survey. Among all exitede patients deaths accounted
for 9.3% (139 of 1489 exits).
a1431 patients with new or established CVD were ever enrolled during the study period
bIncluding: amlodipine, atenolol, bisoprolol, enalapril, hydrochlorothiazide, valsartan; excluding: exclusively frusemide or spironolactone
cAmong 51 asthma patients randomly selected for clinical audit
dTechnically, the MSF guideline did not require cholesterol testing to be performed before calculating a CVD risk score, but qualitative data confirmed most
clinicians waited for cholesterol results before calculating it
eExited patients refers to those that were known to have died, were lost to follow up despite efforts to trace them or who had informed the team that they would
no longer be attending the MSF service
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“telling them what to do”, whereas a “solution-focused”
approach and motivational interviewing techniques were
preferred:
“(Using) words like ‘you are not being honest’, ‘I don’t
feel like you’re telling the truth’,’ if you only would’
… doesn’t work… This concept of patient-centred
care, solution focused therapy, it’s what works.”
Clinical supervisor.
Challenges and facilitators
Here we present the challenges and facilitators related to
patient access, implementation and maintenance that led
to the specific adaptations detailed in the following sec-
tion. Specific individual-level challenges around adher-
ence to medications and healthy living advice are
discussed later.
For patients, the profound impact that war and the
refugee experience had on Syrian refugees’ lives proved
to be the key challenge to delivering effective NCD care
to these patients. Syrian patients’ psychological distress,
social suffering and poverty had enormous implications
for their ability to access and engage with the
programme, as explored in detail in our linked paper
[32]:
“The hypertension goes high … when I get sad and
remember my sons in Syria and they tell me what
happens with them I keep crying and crying then my
hypertension goes high or goes down… I take a
hypertension pill to settle down whenever I read
some news about them.” Syrian patient.
The challenges reported by clinical staff also related to
Syrians’ experience of war. Many staff clearly stated that
they could not manage medical problems in isolation
from the psychosocial issues patients faced. They felt ill-
equipped to deal with Syrian patients’ war-related
trauma and found it personally challenging. They
highlighted the added complexities involved in treating
Syrian versus Jordanian patients due to their perceived
lower education and literacy levels and limited “hope”
for the future. Care delivery was also complicated by the
culture of private medical care and patients’ care seeking
behaviour, with both nationalities tending to visit mul-
tiple concurrent providers and to prefer branded medi-
cation. MSF introduced an appointment system,
contrary to common practice in Jordan, and patients’
initial failure to adhere to appointments proved frustrat-
ing for staff. Clinical and supervisory staff discussed the
challenges inherent in providing chronic NCD care, such
as long consultation times and dealing with the complex-
ity of multi-morbid patients, especially those with renal
failure. They noted that frail, elderly or housebound pa-
tients found physical access to both clinics sites difficult
(via stairs). Finally, staff also described contextual and
cultural challenges around healthy living education and
behaviour change. These included diet and exercise
norms (high fat, high salt diet and low habituation to ex-
ercise for health or leisure), the acceptance of smoking
(especially in men), the obesogenic environment and
most patients’ reliance on medications to provide
solutions.
Staff perceived that facilitators to programme imple-
mentation included excellent patient-staff rapport, posi-
tive experiences of supervision, support and training,
and good teamwork with colleagues. The MSF NCD
guideline reportedly facilitated implementation and was
largely acceptable and “useful”. Staff found it compre-
hensive and adaptable to the local context, serving as a
tool to negotiate patient demands. However, clinical staff
also highlighted the limited guidance on complex multi-
Table 3 Implementation indicator results
Result or comment
Process Indicators
% HTN patients with annual FBG performed Not available (not calculated)
% DM patientsa with annual eye check performed Annualb fundoscopy documented OR referred for retinal screening = 50.8%
% of DM patientsa with micro-albuminuria or urinary protein tested Annualb Albumin creatinine ratio checked in 83.8%
% of DM patientsa on ACE inhibitor with creatinine checked Annualb creatinine check in 98.5%
% of active cohort with health education session at last clinical visit 66.9%c
Number of MHPSS group sessions monthly Average 5.5 per month in 2016 and 2017
% of referred patients attending MHPSS individual counselling Not available as number of internal MHPSS referrals was not captured
Adaptations
Number/% of follow-up consultations performed by nurses 6% in 2017
Key: ACE angiotensin-converting enzyme, FBG fasting blood glucose, HTN hypertension, MHPSS mental health and psychosocial support
aAmong 130 randomly selected diabetic patients’ charts analysed for the clinical audit.
bAnnual referred to the 12 months preceding their most recent appointment.
cAmong patients active in 2017 (n = 4011)
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morbid patients, while management staff requested add-
itional programmatic guidance on defining a pri-
mary level NCD package (“what components are
included…that is not clear”) and predicting referral
needs. Jordanian doctors reportedly perceived the guide-
line as limiting their autonomy and offering “second-
class” generic medication. Several called for a digital ver-
sion facilitating access via smart phone.
Adaptations
Interviewed management and clinical staff described
how the programme, designed around a high-income
country primary care model, adapted dynamically to
identified patient, programmatic and contextual chal-
lenges. The major adaptations are listed below:
 The MHPSS service was an essential addition to the
programme. It was initiated in response to high
rates of mental ill health among Syrian patients and
limited adequate referral options. Starting with
individual counselling sessions, it was later expanded
and reoriented to provide ad hoc psycho-education
sessions in waiting rooms, peer-support groups and
a targeted group ‘living well’ programme combining
health education and psychosocial support.
 By the end of 2017, only 0.5% (n = 24) of enrolled
patients were formally diagnosed with a comorbid
mental health condition and only 3.0% (n = 154)
attended individual counselling sessions. Sixty-six
group-counselling sessions were held in 2016, when
recording began. (MHPSS service data did not cap-
ture numbers enrolled in group or waiting room ses-
sions and were not linked to the general dataset).
Most patients interviewed for this evaluation were
unaware of the MHPSS services. Staff reported is-
sues around social acceptability from both their own
and patients’ perspectives and their reluctance to
“label” patients as requiring MHPSS. Physical space,
patient transport costs and limited patient engage-
ment also proved barriers to patient engagement
with MHPSS services. In response to the initial dis-
trust and low rate of referrals from the programme
doctors, the MHPSS undertook multidisciplinary
staff training sessions and referral rights were ex-
tended to nurses.
 Depression screening was introduced and later
paused as the numbers screening positive
overwhelmed existing service capacity. At the time
of the study, the team reported an ongoing lack of
good quality referral options for patients requiring
prescription of psychotropic medications or
psychiatric input. Therefore, management staff
planned to train one family medicine specialist and
to expand MSF’s medication list to address this
need.
 The humanitarian liaison officer’s social work role
was introduced to address Syrians’ social and
protection needs by linking them with other
available services. It was reportedly underutilised as
few referrals were made by the clinical team.
 Interviewed staff adapted health education messages
to patients’ literacy and education levels, their
limited financial means and their living
environments. Staff also involved family members as
informal treatment supporters.
 A home visit service was introduced in 2015 to
improve access for elderly, housebound and frail
patients. The team (a nurse, doctor and driver)
initially served a 10 km radius from the clinics and
both team and catchment area were later expanded.
 Management staff reported introducing clearer
admission criteria relating to patient vulnerability.
 An appointment system with short message service
(SMS) appointment reminders and an appointment
tool were introduced to increase efficiency. Patients
valued the reminders and the appointment system,
which minimised the long waits and prevented the
perceived favouritism they experienced in the MOH
system. However, they also perceived it as rigid with
services inaccessible outside of prescribed
appointment times. Staff strongly encouraged
patients to attend at their planned appointment day
and time, achieving a 90% adherence rate by 2017.
 Task sharing to nurses of the care of “stable”, less
complex patients achieving clinial control was
introduced and stable patients’ appointment interval
was increased from 1 to 3 months. Family medicine
specialists were added to the team to support
management of more complex patients. Task
sharing had occurred in a very limited manner by
the end of 2017 because of lack of clarity on clinical
activity and patient flow, lack of clear eligibility
criteria, reported resistance from patients and
medical staff, national regulations limiting nurses’
roles. Increasing stable patients’ appointment
interval to 3-monthly required dispensing of 3
months’ worth of medications. This necessitated the
expansion of pharmacy team capacity.
Costs
The total annual financial cost of the NCD programme
from the provider perspective increased annually in par-
allel with greater patient volume, greater service com-
plexity and with the addition of specialist staff. It
increased by 52% from INT$ 4,206,481 in 2015 to INT$
6,400,611 in 2016 and by a further 5% to INT$ 6,739,
438 in 2017. Per-patient-per-year (PPPY) cost increased
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23% from INT$ 1424 (2015) to 1751 (2016), and by 9%
to 1904 (2017), while cost per consultation increased
from INT$ 209 to 253 (2015–2017). The major cost
drivers were human resources (accounting for 38.9–
42.6% of total annual costs) and medications (34.8–
43.2%). The costs are reported in detail in a related
paper [20].
Maintenance
Under the Maintenance domain, we explored the chal-
lenges and facilitators related to programme mainten-
ance at the individual and organisational level.
Individual level
We explored retention in care, medication burden, chal-
lenges and supports around psychosocial issues and ad-
herence to medication and healthy living advice. Routine
cohort data analysis showed that the majority of patients
enrolled during the study period (N = 5045) were
retained in care for over 6 months, with 85% attending a
follow-up appointment six-months (+/− 30 days) after
enrolment; while one-third of enrolled patients had
exited (including 12.5% cumulative loss to follow up and
2.6% deaths) (Table 2).
Over half of adherence survey participants (N = 300;
74.4%) were prescribed four or more MSF-provided
medications (Supplementary material S4B). The majority
(60.4%) also took medications obtained from another
source. Most patients (89%) had very high self-reported
medication adherence scores. While the majority of indi-
vidual interview participants (especially Syrians) declared
themselves “very committed” to taking medications, sev-
eral described stopping, taking intermittently or sharing
medications with those in need. Staff and patients both
emphasised the negative impact of mental distress on
adherence to medications and healthy living advice:
“As I was hearing the stories I thought…this man’s
problem is not that he’s smoking too much. His prob-
lem is that he … experienced sexual violence, phys-
ical violence in prison in Syria… these two are
linked.” Clinical staff member.
Qualitative data confirmed that patients’ medication
adherence and behaviour change was facilitated by sup-
port from family and MSF staff.
Organisational level
Here we explored the costs, challenges faced and
possible modifications necessary to maintain the
programme at organisational and contextual levels.
With senior management, we discussed the lessons
learned that could improve the programme or
facilitate its scale-up, transfer or adaptation to
other settings.
Our costing data supported our interviewees’ impres-
sion that this was an expensive programme. To support
programme planning, we explored potential cost savings
that could be achieved by varying the organisation of
medical consultation workflow, which we presented in a
related paper. The frequency of patient contact with the
facility had the greatest influence on cost-savings; as
more patients were categorised as “stable”, they were
thus more suitable for less expensive nurse review and
for longer review intervals [20].
Many of the challenges elicited were related to deliver-
ing chronic care to a conflict-affected population in a
refugee setting with all the attendant psychosocial, phys-
ical and financial challenges. This proved the key chal-
lenge to implementing and maintaining effective NCD
care in the Syrian refugee population.
MSF staff and stakeholders described the programme
as being delivered within the framework of a complex
and fragmented humanitarian system. Staff struggled to
assist patients in navigating an often opaque, frustrating
and unresponsive referral system.
“The credibility of any service…depends on its ability
to refer upwards…That is just as true for people with
angina … (as it is) for mental health.” Management
staff member.
Referral pathways were limited by: cost (MSF and
UNHCR covered limited essential conditions, proce-
dures and providers); inconsistent availability (some re-
ferral services provided on short-term project bases);
and bureaucracy (MSF was required to refer to MOH
services via an intermediary).
In addition, the programme operated in a middle-
income country of the Middle East with well-established
health systems, regulations and policies, which tightly
regulated humanitarian actors’ activities. Policies in-
cluded the requirement that medications must be locally
purchased (which increased costs); the lack of govern-
ment focal point or set of regulations governing NGOs;
significant bureaucratic delays; and strict regulation (for
example around prescribing of psychotropic medica-
tions, nurse-prescribing and permission for Syrian clini-
cians to practice in Jordan).
In terms of facilitators of programme maintenance,
management staff highlighted that the availability of
highly qualified Jordanian professional staff facilitated
implementation of this complex, multidisciplinary model
of care but that this level of staffing would be unavail-
able in other settings where MSF works.
Qualitative data highlighted the importance placed by
MSF staff on providing a good quality service that
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fulfilled MSF’s humanitarian remit. There was a per-
ceived tension between their desire to continually im-
prove the programme and the need to consider long-
term planning and a potential future handover. While
the MOH was considered by some management staff as
the likely handover partner, they emphasised its limited
capacity and the gulf between current MSF and MOH
models of NCD care.
The internal debate within MSF around the appropri-
ateness of a humanitarian NGO engaging in chronic
NCD care and their relative inexperience in doing so
also posed its own unique challenge to the maintenance
of the programme, as described here:
“An NCD Programme is a relatively recent depart-
ure for MSF and it is getting very close to the divid-
ing line between humanitarian and development
aid. (There is a) general sense among the humani-
tarian community that NCDs are an epidemic and
need to be dealt with, but I am not sure we have
…(a clear) view of how this should be managed...”
Management staff member.
Several MSF management staff noted the particular
challenge involved in adapting MSF’s more familiar
approach, characterised as providing relatively short-
term solutions to health care gaps in populations in
crisis, to the setting of chronic disease care. Several
also questioned the sustainability and/or the potential
to hand over the complex Irbid care model and men-
tioned the Jordanian MOH and other NGOs as po-
tential hand over partners. However, senior MSF staff
highlighted the rationale for maintaining the specific
vertical programme in Irbid. It served as an oppor-
tunity for MSF to “learn by doing” and to understand
the essential components of NCD care. To continue
operating in the Jordanian context, a middle-income
country with established systems, regulations and pol-
icies, required a different type of engagement and ne-
gotiation with authorities compared to other contexts
where MSF has traditionally worked, which may have
fewer resources and weaker systems.
Several staff members suggested that MSF could en-
gage more closely with pre-existing health systems in de-
signing future NCD interventions, and could build on
their HIV service model, by maximising task sharing and
decentralisation of care to community level.
Discussion
Our mixed methods evaluation guided by the RE-AIM
framework has helped to characterise the implementa-
tion strategies, challenges and adaptations made to a
complex, multidisciplinary intervention providing pri-
mary level NCD care in a humanitarian setting.
Programme coverage, acceptability and access to chronic
care in Jordan
The MSF Irbid NCD Programme provided free-of-
charge care to a limited patient cohort, covering approxi-
mately one quarter of the target adult Syrian population
and a number of Jordanians. Enrolled patients’ NCD risk
factors and disease prevalence reflected regional norms
[19, 30, 39, 40]. The programme was largely acceptable
to patients, staff and stakeholders, although patients
were frustrated by the siloed approach to care and lim-
ited access to referral services.
One key finding, consistent with the literature, was
the lack of access to affordable NCD care both for
non-MSF patients and for MSF patients seeking care
for conditions not covered by MSF [19, 29–31]. Syr-
ian refugees’ access to NCD care was likely dimin-
ished following Jordanian government policy to
significantly increase their MOH co-payments to “for-
eigner” levels in 2018, which was later reversed in
2019 [31]. McNatt et al. reported that, following the
policy change, NCD patients increasingly sought care
from the NGO rather than MOH sector, attending
multiple providers to create comprehensive NCD care
for themselves. Patients in their study found this
process financially and emotionally burdensome. MSF
could also note their finding that the burden of indir-
ect costs of clinic attendance (transport, lost work
time) potentially outweighed the benefits of free
NGO-provided care [31].
Delivering chronic care in a humanitarian setting
Many of the challenges in programme implementation
encountered by MSF were related to a humanitarian or-
ganisation delivering chronic disease care to a conflict-
affected population. The impact of Syrian patients’ ex-
perience of war, loss and social suffering on their en-
gagement with NCD care was a key finding [32]. The
lack of accessible and consistent specialist care referral
pathways for NCD complications in this context has
been described in the literature [29, 41]. MSF's tempor-
ary solution via other international NGOs was
dependent on short-term project-based funding. For fu-
ture NCD programme design, we recommend attempt-
ing to secure essential referral pathways (e.g.,
ophthalmology, cardiology, nephrology) that are accept-
able, accessible and affordable for patients, and linked
directly with MOH services, where possible. We ac-
knowledge that this may be extremely challenging, espe-
cially in low-income countries with constrained health
systems, and would require agreement on financing,
clear referral criteria and continuity of information.
Strengthening NCD care within the MOH system in hu-
manitarian settings also requires greater focus and finan-
cing of NCDs by major donors. Other challenges
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identified were related to the specific Jordanian context,
a middle-income country with well-established health
systems, regulations and policies, which tightly regulated
humanitarian actors’ activities compared to other set-
tings with weaker systems.
Key programme adaptations
This MSF programme repeatedly adapted to patient and
programmatic needs. Key adaptations included the
addition of a specific, culturally-relevant MPHSS service,
the introduction of the HLO social work role and the
development of specific referral criteria for MHPSS, so-
cial work and external services [32]. There appeared to
be scope to further improve both patient education (by
taking a more solution-focused approach, utilising pa-
tients’ own strengths, skills and intrinsic motivation) and
medication adherence support [42]. Further work is
needed to develop adherence measurement and support
tools in this population but joint decision making with
patients and involving treatment supporters may prove
valuable, as found in other contexts [43].
MSF also adapted recall and data collection tools to
chronic care delivery by introducing specific appoint-
ment times, appointment reminders, individual patient
files and a patient-level electronic database. The latter
allowed for cohort analysis, as previously demonstrated
by the UN Relief and Works Agency for Palestinian refu-
gees (UNRWA) [44–46]. Key lessons included the need
for a fit-for-purpose and actionable information system
and the need to establish informative indicators without
overburdening staff with data collection.
Effectiveness of the programme
The programme appeared to achieve good intermediate
clinical outcomes for hypertension and diabetes. These
findings reflect those reported by MSF and UNRWA in
similar humanitarian settings [21, 44, 47]. However, it
should be noted that we know little about the prevalence
or outcomes of major complications of these illnesses,
such as heart failure, ischaemic heart disease and periph-
eral vascular disease. This is partly because these condi-
tions are difficult to measure at primary care level,
requiring equipment and trained personnel, but also be-
cause of the limited affordable specialist care available to
MSF patients for diagnosis of these conditions in Jordan
[29, 48]. The apparently good asthma control outcomes
relied on patient self-report and may have reflected poor
recording of this variable. The low rate of statin coverage
is an important finding. Since this is a proven, effective
strategy to reduce mortality, we suggest that further staff
training on CVD secondary prevention, further audits
(ideally as part of a quality improvement strategy), and
the introduction of fixed dose combination CVD sec-
ondary prevention drugs may boost statin prescribing
[48–50]. In terms of hard outcomes, such as mortality,
2.6% of the cohort was known to have died during the
study period. This is not surprising given this was an
elderly population with multi-morbidity and limited ac-
cess to specialist care. It may be underreported, since
most deaths took place in hospitals or in the community
and, in many cases, cause of death was not known. Fur-
ther study of death rates and cause of death is war-
ranted, necessitating longer follow up periods.
Maintaining the programme
We identified a number of key challenges to maintaining
the programme and areas for further improvement. Prin-
cipal among these was cost. MSF management staff per-
ceived the programme to be costly but, to our
knowledge, there are no available published data to dir-
ectly compare the programme’s costs with similar ser-
vices, either in the Middle East region or in other
humanitarian settings. This programme was more costly
than MSF-reported incremental PPPY costs of adding
NCD care to existing services in Mweso, Democratic Re-
public of Congo [INT$222 (2015)] and in Eswatini
[INT$441 (2016)] [7, 33]. Limited data on NCD care
from countries affected by the Syrian crisis have focused
on the costs of secondary or tertiary level care [51–53].
High costs were at least partly responsible for MSF lim-
iting the service’s coverage and scope. However, some
adaptations introduced by MSF, triaging the cohort pa-
tients by disease complexity and control, introducing
task sharing to nurses and spacing review appointments
for stable patients could result in cost savings, as dis-
cussed elsewhere [20]. It was possible to employ family
medicine specialists to manage the more complex pa-
tients in Irbid because of the availability of highly quali-
fied Jordanian staff, but such staff would likely be
unavailable in many humanitarian settings with more
constrained health systems. It is therefore essential to
provide programmatic and clinical written guidance ap-
propriate to different contexts, which could potentially
be supported by technology, such as telemedicine and/or
mHealth decision support tools, as trialled by other ac-
tors in Lebanon [54].
Humanitarian actors’ modus operandi is to rapidly iden-
tify needs and bring healthcare to vulnerable or margina-
lised populations, then withdraw or hand over activities,
as the context dictates. This approach is not consistent
with the continuous care required for chronic conditions
and may explain interviewed participants’ apparent dis-
comfort with the lack of a “handover strategy” and “verti-
cal” nature of the programme. Senior staff emphasised the
role the Irbid programme played as one of MSF’s pilot
NCD-specific programmes, serving both to anchor the or-
ganisation in Jordan and as a training programme. While
the programme served MSF well as a learning ground it
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was unlikely to be scalable in Jordan or reproducible in
other humanitarian settings, mainly due to cost and the
required numbers and skill mix of staff.
MSF and other humanitarian actors recognise that in-
tegration of NCD care within existing health systems,
ideally at primary care level, may be the optimal ap-
proach [2]. Integration may provide an opportunity for
health system strengthening, particularly in contexts
where resource-poor health systems have previously fo-
cused on episodic emergency or infectious disease care
and have limited capacity to provide chronic disease care
[1, 55, 56]. Designing future NCD services may require a
comprehensive analysis of the pre-existing health sys-
tem’s readiness to manage NCDs, particularly at primary
care level, and its resilience in the face of crises.
Lessons learned and potential solutions
The lessons learned and adaptations made as the
programme evolved may be relevant to MSF, the MOH
and other humanitarian actors and may be transferable
to other settings. A number of approaches are inter-
linked and could potentially achieve several things: in-
creased patient-centeredness, increased cost-efficiency
for patients and provider, and increased coverage. These
goals could be achieved by reducing facility-based con-
tact through decentralisation, enhancing community-
level care and supporting patient self-management.
These approaches could involve further task sharing to
nurses or other non-physician health worker cadres,
such as community workers or volunteers. Several as-
pects of the care pathway could be shifted to the com-
munity level, including prevention and sensitisation
activities, diagnosis, treatment monitoring and adher-
ence support. Patient centeredness (taking a holistic, re-
sponsive approach and actively collaborating with
patients and families) could involve either providing
“one stop shop” comprehensive primary care at a single
facility visit or bringing care to the patient via outreach
workers or home care teams [34, 57, 58]. Adherence and
self-management could be supported via mobile phone
or wearable technology or through peer support groups
led by community workers or peers [56]. Clearly, the
specific design and the successful implementation of
these strategies would be context-dependent and would
rely on local acceptance by patients, staff and the med-
ical fraternity as well as political and regulatory support.
Several actors in Jordan have introduced community-
based healthy living interventions or peer support
groups for people with diabetes on project or pilot bases
[59–62]. Some reported positively impacting intermedi-
ate clinical outcomes, such as weight and blood glucose
levels. However, cost effectiveness, sustainability, accept-
ability or user experiences were not formally examined.
The recently published HOPE4 trial also demonstrated
the benefits of a community-based package of care for
hypertension in a non-humanitarian setting [63].
Strengths and limitations
To the best of our knowledge this is the first study to
comprehensively describe a mixed-methods evaluation
of an NCD service in a humanitarian setting guided by
the RE-AIM framework. It builds on our previous use of
the framework in the Democratic Republic of Congo [6,
7]. We made comprehensive use of RE-AIM, addressing
each of the domains and including more extensive ex-
planatory qualitative and costing analyses than are often
employed in the RE-AIM literature [15]. We could com-
ment in only a limited way on adoption and participa-
tion as they have been traditionally used, since this
intervention took place at a single site rather than in-
volving multiple sites/providers. We included process in-
dicators relevant to Quality of Care in several domains.
Alternatively these could be grouped under the “Imple-
mentation-fidelity” subdomain.
The challenges of conducting research in humanitarian
contexts, the need to improve evaluation of humanitar-
ian programmes in general and the lack of evidence de-
scribing the effectiveness of NCD care models in
humanitarian settings have previously been noted [3,
10–13, 64]. We demonstrated that implementation re-
search can be conducted while placing limited burden
on staff and patients. We also highlighted the challenges
in retrospectively evaluating humanitarian programmes,
which tend to be highly responsive to changing contexts,
and in analysing routinely collected data. For example, it
was not feasible for us to include a comparator group or
use a quasi-experimental design, such as interrupted
time series, given the dynamic and unique nature of the
programme. Indicators designed for this evaluation have
contributed to the ongoing development by humanitar-
ian organisations of a set of shared NCD indicators. A
number of our indicators could not be measured due to
failure to collect or limited usability of data and we em-
phasise the need to co-develop indicators with imple-
menters, especially when using routine programmatic
data.
We note there is a need to replicate this model to dis-
tinguish what is essential to this site rather than essential
across settings. We also note our limited understanding
of the situation of people with NCDs who did not reach
care, for instance, those who were undiagnosed, who
attended irregularly, or who could not physically access
services. Similarly, we did not interview patients cur-
rently attending MOH or other NGO services, although
our findings about alternative NCD services reflect those
of other authors [31]. We note, finally, that social desir-
ability bias may have influenced results of the qualitative
data and of the self-report medication adherence survey,
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which was mainly administered by the data collectors ra-
ther than by patients as intended.
Future research and evaluation
As discussed, there is a need to design and perform im-
plementation research around the streamlined high-
quality NCD programme models described above in hu-
manitarian settings, particularly facilitating access for
mobile or dispersed populations. Designing and evaluat-
ing novel ways to improve access to diagnosis and man-
agement of NCD complications at primary care level is
also essential, which could include use of telemedicine,
mobile technology or artificial intelligence-supported
diagnosis or clinical decision tools [48, 54, 64]. We rec-
ommend that future research should focus on elucidat-
ing programme impact, where possible, using methods
such as causal inference frameworks and prospective
interrupted time series analyses. Longer study durations
would facilitate examination of hard outcomes, such as
cardiac events and deaths. Further exploration of access
and quality of care issues, utilising patient quality of life
and satisfaction outcomes and disaggregating by sex,
would also be useful. In addition, patient-level costing
studies, examining direct and indirect patient costs, and
cost-effectiveness studies are lacking.
Conclusion
RE-AIM has proven a valuable tool to guide the evalu-
ation of a complex intervention in a protracted humani-
tarian crisis setting. Most elements of the MSF
programme were perceived as acceptable to patients,
staff and stakeholders, whereas adaptations were re-
quired to improve the acceptability of the MHPSS ser-
vices. It was accessible and affordable for the
programme’s cohort of enrolled patients, while achieving
good intermediate clinical outcomes. However, the
programme had limited coverage and the current model
was both costly and complex and therefore challenging
for other actors to emulate or to translate to other, more
financially constrained settings. We propose that simpli-
fication of the care model, reduction of costs and use of
technology could improve effectiveness and efficiency
without reducing acceptability and may improve trans-
ferability to other settings.
Key recommendations
1. Patient-centred. Adopt a contextualised, patient-
centred approach where possible. For example, de-
liver care at community level, support patients and
families to self-manage and provide holistic, “one-
stop-shop” care at facility visits. Elicit and respond
to patient priorities. In this case they were:
consistent, affordable medication and respectful and
caring staff.
2. Complex, yet efficient care. There is a broad
range of patient complexity involved in NCD care,
from asymptomatic hypertensive patients to frail,
elderly patients with complex disease involving
polypharmacy and multi-morbidity. It is important
to acknowledge this complexity and the holistic ap-
proach needed when drafting guidelines and design-
ing services. Consultations are time consuming and
patients may require frequent review. Where appro-
priate, a context-adapted, algorithm-driven ap-
proach may facilitate task sharing to nurses of the
stable, less complex patients. Introducing fixed dose
combination pills, for example, may reduce pill bur-
den and ease adherence, while simplifying prescrib-
ing and workload in relevant settings.
3. Continuum of care. NCDs require a continuum of
care involving primary prevention, diagnosis and
treatment, prevention and management of
complications, psychosocial support, rehabilitation
and palliation. A multi-disciplinary team would
ideally deliver this package of care, where available.
4. Mental health and psychosocial support should
be included as an integral part of primary level
NCD services in humanitarian settings. This may be
integrated or provided by partner organisations.
Provide a tiered approach to MHPSS according to
need: 1. Basic support available to all, 2.
Psychosocial or peer support groups for specific
patient groups (such as teenagers with diabetes),
and 3. Individualised counselling and medical
intervention.
5. Adapted healthy living advice. Adapt advice to
patients’ constrained circumstances and use proven
techniques such as solution-focused counselling and
motivational interviewing.
6. Access to referral services. A predictable
proportion of patients will require referral for
screening, diagnosis or treatment of NCD-related
complications. However, it may be difficult to se-
cure essential referral pathways (e.g. ophthalmology,
cardiology, nephrology) that are acceptable, access-
ible and affordable for patients. Therefore, it is es-
sential to maximise the quality of primary NCD
care to prevent, identify and effectively manage
complications.
7. Low cost to patients yet cost-efficient for pro-
viders. The ideal way to ensure access is to provide
free-of-charge care to patients, where possible. The
model of NCD care presented here was relatively
costly from the provider perspective, especially in
terms of HR and drugs. We have shown that sav-
ings could be made by reducing the frequency of
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facility-based contact and by introducing context-
adapted procurement practices.
8. Health system strengthening. Integrate with host
health systems where possible and engage in health
system strengthening appropriate to the local
context, in order to ensure sustainability and
facilitate movement of patients from private to state
health systems. This may require a comprehensive
analysis of the pre-existing health system readiness
to manage NCDs, particularly at primary care level,
and its resilience in the face of crisis, before
embarking on an NCD intervention.
9. Monitoring and evaluation adapted to chronic
care. Implement more broadly the structures,
reporting mechanisms and indicators developed
within the MSF Irbid programme to reflect the
needs of a chronic disease programme.
10. Research. Engage patients and stakeholders in the
design and evaluation of new models of NCD care
in humanitarian settings. These may involve
simplification, greater use of task sharing,
decentralisation of care to the community level, and
use of technology for patient and provider support.
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